Showing results (181-190 of 320) with videos related to
Sort By:
Pageof 32
Experimental Cell Research|August 27, 2013
Cell migration or cytokinesis and proliferation?--revisiting the "go or grow" hypothesis in cancer cells in vitroTamás Garay, Éva Juhász, Eszter Molnár, et al.Journal of Medicinal Chemistry|November 16, 2020
Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated EffluxJulia H Bormio Nunes, Sonja Hager, Marlene Mathuber, et al.Journal of Medicinal Chemistry|February 10, 2009
Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agentsLaurent Ingrassia, Florence Lefranc, Janique Dewelle, et al.Lung Cancer (Amsterdam, Netherlands)|November 5, 2013
High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancerMatthias Preusser, Anna S Berghoff, Walter Berger, et al.Oncotarget|November 19, 2013
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axisDaniela Lötsch, Elisabeth Steiner, Klaus Holzmann, et al.Oncotarget|September 22, 2016
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancerMohamed A Ahmed, Edgar Selzer, Wolfgang Dörr, et al.Plos Genetics|December 7, 2011
Targeted proteolysis of plectin isoform 1a accounts for hemidesmosome dysfunction in mice mimicking the dominant skin blistering disease EBS-OgnaGernot Walko, Nevena Vukasinovic, Karin Gross, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|December 5, 2018
Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACTMatthias Unseld, Robert Mader, Lukas Baumann, et al.Chemical Communications (Cambridge, England)|February 12, 2013
Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug deliveryVerena Pichler, Josef Mayr, Petra Heffeter, et al.Journal of Medicinal Chemistry|July 13, 2013
New 5-Aryl-1H-imidazoles display in vitro antitumor activity against apoptosis-resistant cancer models, including melanomas, through mitochondrial targetingVéronique Mathieu, Emilie Van Den Berge, Justine Ceusters, et al.Pageof 32